Barclays PLC Increases Stake in Proto Labs, Inc. (NYSE:PRLB)

Barclays PLC increased its holdings in Proto Labs, Inc. (NYSE:PRLB) by 66.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,633 shares of the industrial products company’s stock after purchasing an additional 17,017 shares during the quarter. Barclays PLC owned 0.17% of Proto Labs worth $1,252,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Canada Pension Plan Investment Board bought a new stake in shares of Proto Labs in the 2nd quarter valued at about $37,000. KBC Group NV increased its stake in Proto Labs by 69.3% in the 3rd quarter. KBC Group NV now owns 1,541 shares of the industrial products company’s stock worth $45,000 after purchasing an additional 631 shares during the period. Point72 Asia Singapore Pte. Ltd. lifted its position in Proto Labs by 40.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,108 shares of the industrial products company’s stock valued at $121,000 after purchasing an additional 1,186 shares during the last quarter. Meeder Asset Management Inc. boosted its stake in shares of Proto Labs by 72.3% during the third quarter. Meeder Asset Management Inc. now owns 4,465 shares of the industrial products company’s stock valued at $131,000 after purchasing an additional 1,873 shares during the period. Finally, Paloma Partners Management Co bought a new position in shares of Proto Labs in the third quarter worth approximately $201,000. 84.54% of the stock is owned by institutional investors.

Proto Labs Stock Up 0.1 %

PRLB opened at $36.66 on Tuesday. The company has a market capitalization of $898.54 million, a PE ratio of 39.00 and a beta of 1.45. The firm has a 50-day simple moving average of $40.09 and a two-hundred day simple moving average of $33.54. Proto Labs, Inc. has a 52 week low of $25.75 and a 52 week high of $45.15.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings results on Friday, November 1st. The industrial products company reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.15. The company had revenue of $125.60 million during the quarter, compared to analyst estimates of $121.38 million. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. The firm’s revenue was down 3.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.31 earnings per share. As a group, sell-side analysts expect that Proto Labs, Inc. will post 0.84 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $40.00 price objective on shares of Proto Labs in a research report on Monday, November 4th. Craig Hallum boosted their price target on Proto Labs from $30.00 to $36.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Proto Labs in a report on Friday, November 1st. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $40.33.

Proto Labs Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.